Royal Bank Of Canada Ab Cellera Biologics Inc. Transaction History

Royal Bank Of Canada

  • $479 Billion
  • Q4 2024

A detailed history of Royal Bank Of Canada transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 406,991 shares of ABCL stock, worth $1.03 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
406,991
Previous 407,384 0.1%
Holding current value
$1.03 Million
Previous $1.06 Million 12.99%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$2.48 - $3.15 $974 - $1,237
-393 Reduced 0.1%
406,991 $1.19 Million
Q3 2024

Nov 14, 2024
SELL
$2.39 - $3.49 $3,561 - $5,200
-1,490 Reduced 0.36%
407,384 $1.06 Million
Q2 2024

Aug 14, 2024
BUY
$2.73 - $4.73 $45,091 - $78,125
16,517 Added 4.21%
408,874 $1.21 Million
Q1 2024

Nov 05, 2024
SELL
$4.29 - $5.97 $70,857 - $98,606
-16,517 Reduced 4.04%
392,357 $1.78 Million
Q1 2024

May 15, 2024
BUY
$4.29 - $5.97 $18,181 - $25,300
4,238 Added 1.09%
392,357 $1.78 Million
Q4 2023

Feb 14, 2024
SELL
$3.91 - $5.93 $25,348 - $38,444
-6,483 Reduced 1.64%
388,119 $2.22 Million
Q3 2023

Nov 14, 2023
SELL
$4.6 - $7.95 $428,917 - $741,281
-93,243 Reduced 19.11%
394,602 $1.82 Million
Q2 2023

Aug 14, 2023
SELL
$5.66 - $7.59 $3.75 Million - $5.04 Million
-663,416 Reduced 57.63%
487,845 $3.15 Million
Q1 2023

May 15, 2023
BUY
$7.31 - $11.18 $268,620 - $410,831
36,747 Added 3.3%
1,151,261 $8.68 Million
Q4 2022

Feb 14, 2023
BUY
$9.48 - $14.52 $246,868 - $378,115
26,041 Added 2.39%
1,114,514 $11.3 Million
Q3 2022

Nov 14, 2022
BUY
$9.2 - $13.68 $3.04 Million - $4.53 Million
330,870 Added 43.67%
1,088,473 $10.8 Million
Q2 2022

Aug 15, 2022
SELL
$5.72 - $10.65 $398,626 - $742,198
-69,690 Reduced 8.42%
757,603 $8.07 Million
Q1 2022

May 16, 2022
SELL
$7.46 - $14.14 $127,334 - $241,355
-17,069 Reduced 2.02%
827,293 $8.07 Million
Q4 2021

Feb 14, 2022
BUY
$12.99 - $17.73 $8.55 Million - $11.7 Million
657,862 Added 352.74%
844,362 $12.1 Million
Q3 2021

Nov 15, 2021
BUY
$14.85 - $21.34 $488,906 - $702,576
32,923 Added 21.44%
186,500 $3.74 Million
Q2 2021

Aug 16, 2021
BUY
$20.19 - $34.17 $3.1 Million - $5.25 Million
153,577 New
153,577 $3.38 Million

Others Institutions Holding ABCL

# of Institutions
165
Shares Held
120M
Call Options Held
233K
Put Options Held
339K
View Full List

About AbCellera Biologics Inc.

ABCL Quotes by TradingView
  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $719M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email